Sinopharm SHTDF Stock
Sinopharm Price Chart
Sinopharm SHTDF Financial and Trading Overview
| Sinopharm stock price | 2.46 USD |
| Previous Close | 3.28 USD |
| Open | 3.28 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 3.28 - 3.28 USD |
| 52 Week Range | 1.8 - 3.63 USD |
| Volume | 23 USD |
| Avg. Volume | 463 USD |
| Market Cap | 10.52B USD |
| Beta (5Y Monthly) | 0.819157 |
| PE Ratio (TTM) | 8.631579 |
| EPS (TTM) | 0.4 USD |
| Forward Dividend & Yield | 0.11 (3.39%) |
| Ex-Dividend Date | June 20, 2023 |
| 1y Target Est | N/A |
SHTDF Valuation Measures
| Enterprise Value | 57.77B USD |
| Trailing P/E | 8.631579 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.019000752 |
| Price/Book (mrq) | 0.15113814 |
| Enterprise Value/Revenue | 0.104 |
| Enterprise Value/EBITDA | 2.292 |
Trading Information
Sinopharm Stock Price History
| Beta (5Y Monthly) | 0.819157 |
| 52-Week Change | 42.60% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.63 USD |
| 52 Week Low | 1.8 USD |
| 50-Day Moving Average | 3.36 USD |
| 200-Day Moving Average | 2.63 USD |
SHTDF Share Statistics
| Avg. Volume (3 month) | 463 USD |
| Avg. Daily Volume (10-Days) | 160 USD |
| Shares Outstanding | 1.34B |
| Float | 183.2M |
| Short Ratio | N/A |
| % Held by Insiders | 0.012% |
| % Held by Institutions | 53.28% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.82 |
| Trailing Annual Dividend Yield | 25.00% |
| 5 Year Average Dividend Yield | 343.00% |
| Payout Ratio | 0.2728 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 1.55% |
| Operating Margin (ttm) | 4.14% |
| Gross Margin | 8.60% |
| EBITDA Margin | 4.55% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 553.68B USD |
| Revenue Per Share (ttm) | 177.45 USD |
| Quarterly Revenue Growth (yoy) | -85.39% |
| Gross Profit (ttm) | 47.43B USD |
| EBITDA | 25.21B USD |
| Net Income Avi to Common (ttm) | 8.64B USD |
| Diluted EPS (ttm) | 0.38 |
| Quarterly Earnings Growth (yoy) | -74.59% |
Balance Sheet
| Total Cash (mrq) | 55.22B USD |
| Total Cash Per Share (mrq) | 129.59 USD |
| Total Debt (mrq) | 69.59B USD |
| Total Debt/Equity (mrq) | 63.22 USD |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 21.702 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Sinopharm
| Country | United States |
| State | N/A |
| City | Shanghai |
| Address | Sinopharm Group Building |
| ZIP | 200023 |
| Phone | 86 21 2305 2666 |
| Website | https://www.sinopharmgroup.com.cn |
| Industry | Medical Distribution |
| Sector(s) | Healthcare |
| Full Time Employees | 114766 |
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Q&A For Sinopharm Stock
What is a current SHTDF stock price?
Sinopharm SHTDF stock price today per share is 2.46 USD.
How to purchase Sinopharm stock?
You can buy SHTDF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sinopharm?
The stock symbol or ticker of Sinopharm is SHTDF.
Which industry does the Sinopharm company belong to?
The Sinopharm industry is Medical Distribution.
How many shares does Sinopharm have in circulation?
The max supply of Sinopharm shares is 3.15B.
What is Sinopharm Price to Earnings Ratio (PE Ratio)?
Sinopharm PE Ratio is 6.15000000 now.
What was Sinopharm earnings per share over the trailing 12 months (TTM)?
Sinopharm EPS is 0.4 USD over the trailing 12 months.
Which sector does the Sinopharm company belong to?
The Sinopharm sector is Healthcare.